These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17324475)

  • 41.
    Emmerich TD; Hayes JM
    Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Memory formation in old age requires GSK-3β.
    Koike R; Takaichi Y; Soeda Y; Takashima A
    Aging Brain; 2021; 1():100022. PubMed ID: 36911517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic N-Acetylcysteine Treatment Prevents Amphetamine-Induced Hyperactivity in Heterozygous
    Lai CC; Baskaran R; Tsao CY; Tuan LH; Siow PF; Palani M; Lee LJ; Liu CM; Hwu HG; Lee LJ
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drugs and Endogenous Factors as Protagonists in Neurogenic Stimulation.
    Chiareli RA; Marques BL; de Carvalho GA; de Souza RTV; Santana PHG; Santiago HC; Pinto MCX; Birbrair A; Parreira RC; Ulrich H; Resende RR
    Stem Cell Rev Rep; 2022 Dec; 18(8):2852-2871. PubMed ID: 35962176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Schizophrenia Hypothesis: Autonomic Nervous System Dysregulation of Fetal and Adult Immune Tolerance.
    Carnac T
    Front Syst Neurosci; 2022; 16():844383. PubMed ID: 35844244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deletion of Schizophrenia Susceptibility Gene Ulk4 Leads to Abnormal Cognitive Behaviors via Akt-GSK-3 Signaling Pathway in Mice.
    Hu L; Zhou BY; Yang CP; Lu DY; Tao YC; Chen L; Zhang L; Su JH; Huang Y; Song NN; Chen JY; Zhao L; Chen Y; He CH; Wang YB; Lang B; Ding YQ
    Schizophr Bull; 2022 Jun; 48(4):804-813. PubMed ID: 35522199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases.
    Marosi M; Arman P; Aceto G; D'Ascenzo M; Laezza F
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. G-CSF augments the neuroprotective effect of conditioned medium of dental pulp stem cells against hypoxic neural injury in SH-SY5Y cells.
    Ahmadi F; Salmasi Z; Mojarad M; Eslahi A; Tayarani-Najaran Z
    Iran J Basic Med Sci; 2021 Dec; 24(12):1743-1752. PubMed ID: 35432810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adult neural stem cells and schizophrenia.
    Hu L; Zhang L
    World J Stem Cells; 2022 Mar; 14(3):219-230. PubMed ID: 35432739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway.
    Vallée A
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. S-SCAM inhibits Axin-dependent synaptic function of GSK3β in a sex-dependent manner.
    Kearney G; Grau D; Nieves Torres D; Shin SM; Lee SH
    Sci Rep; 2022 Mar; 12(1):4090. PubMed ID: 35260764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Misregulation of Wnt Signaling Pathways at the Plasma Membrane in Brain and Metabolic Diseases.
    Karabicici M; Azbazdar Y; Iscan E; Ozhan G
    Membranes (Basel); 2021 Oct; 11(11):. PubMed ID: 34832073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of
    Loi M; Gennaccaro L; Fuchs C; Trazzi S; Medici G; Galvani G; Mottolese N; Tassinari M; Giorgini RR; Milelli A; Ciani E
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Oxindole Derivatives, New Promising GSK-3β Inhibitors as One of the Potential Treatments for Alzheimer's Disease-A Molecular Dynamics Approach.
    Czeleń P; Szefler B
    Biology (Basel); 2021 Apr; 10(4):. PubMed ID: 33920768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioral Deficits in Mice with Postnatal Disruption of
    Gavrilovici C; Jiang Y; Kiroski I; Sterley TL; Vandal M; Bains J; Park SK; Rho JM; Teskey GC; Nguyen MD
    Cereb Cortex Commun; 2021; 2(1):tgaa096. PubMed ID: 33615226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GSK-3β Disrupts Neuronal Oscillatory Function to Inhibit Learning and Memory in Male Rats.
    Albeely AM; Williams OOF; Perreault ML
    Cell Mol Neurobiol; 2022 Jul; 42(5):1341-1353. PubMed ID: 33392916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus.
    Mizuki Y; Sakamoto S; Okahisa Y; Yada Y; Hashimoto N; Takaki M; Yamada N
    Int J Neuropsychopharmacol; 2021 May; 24(5):367-382. PubMed ID: 33315097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Convergent genomic and pharmacological evidence of PI3K/GSK3 signaling alterations in neurons from schizophrenia patients.
    Stertz L; Di Re J; Pei G; Fries GR; Mendez E; Li S; Smith-Callahan L; Raventos H; Tipo J; Cherukuru R; Zhao Z; Liu Y; Jia P; Laezza F; Walss-Bass C
    Neuropsychopharmacology; 2021 Feb; 46(3):673-682. PubMed ID: 33288841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site.
    Rippin I; Khazanov N; Shirley Ben Joseph ; Kudinov T; Berent E; Arciniegas Ruiz SM; Marciano D; Levy L; Gruzman A; Senderowitz H; Eldar-Finkelman H
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia.
    Nakao K; Singh M; Sapkota K; Hagler BC; Hunter RN; Raman C; Hablitz JJ; Nakazawa K
    Neuropsychopharmacology; 2020 Dec; 45(13):2207-2218. PubMed ID: 32859995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.